Nuvectis Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $6.7M
Liabilities Breakdown FY2021
Total Liabilities: $2.4M
Asset Breakdown
Total Assets: $6.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.7M | 86.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $915.0K | 13.7% |
Liabilities Breakdown
Total Liabilities: $2.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 43.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.4M | 56.3% |